Document text
Principal Investigator: Xiaobo Zhou
Organization: UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
Fiscal Year: 2024
Award: $312,000
Funding agency: National Institute of General Medical Sciences
Abstract
The goal of this project is to develop a platform called mRNAdesigner, an integrated deep learning model to
optimize 5'UTR, codon usage, and 3'UTR at same time, which enables users to design the optimal mRNA
sequence to enhance protein expression level, thus to improve the mRNA translation efficiency
mRNA medicines have several beneficial features: safety, efficacy, production, and speed. It is a significant
challenge for all of the researchers to maximize the translation efficiency of mRNA vaccine. Multiple factors are
involved to regulate the stability and efficiency of mRNA, including 5' untranslated region (UTR), 3' UTR, codon
et al, and several in silico approaches have been developed to optimize these factors respectively However, as
these factors always function together during the translation of mRNA, and individual optimization is insufficient.
Thus, a novel integrated deep learning model for these factors is needed to comprehensively enhance the
stability and efficiency of mRNA medicine. We propose to develop a platform mRNAdesigner that will address
the challenges in design of mRNA sequence to enhance mRNA stability and translation efficiency, and thus
provide important information for the development and optimization of mRNA vaccines. mRNAdesigner includes
three components: mRNAbase, mRNAoptimizer, and mRNAviewer. mRNAbase is a database to collect high
translational efficiency gene data, the optimized mRNA sequence of ORF, 5' UTR and 3'UTR for any target
proteins, the energy, secondary structure, and functional annotation of those optimized mRNA sequence of ORF;
mRNAoptimizer, in silico deep learning optimization of mRNA sequence, provides a fast methodology to
investigate all possible integration of the ORF, 5' UTR and 3'UTR and identify the optimal mRNA sequence; and
mRNAviewer to visualize the optimized mRNA sequences, the secondary structures and the related functions.
Finally, the integrated models by designing the 5'UTR, codon, and 3'UTR sequence for representative will be
experimentally validate in vitro and in vivo. Software prototypes mRNAdesigner including mRNAbase,
mRNAoptimizer, and mRNAviewer will be made publicly available to the research community via a project
website at https:/ccsm.uth.edu/NSF-mRNAdesigner.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><2019-nCoV vaccine><3' Untranslated Regions><3'UTR><5' Untranslated Regions><5'UTR><Affect><Antigens><Atlases><BNT 162b2><BNT162b2><Biology><Body Tissues><COVID-19 vaccine><COVID-19 virus><COVID19 virus><Cancers><Cell Body><Cells><Clinical><Clinical Trials><CoV-2><CoV2><Codon><Codon Nucleotides><Communicable Diseases><Communities><Computer software><Data><Data Bases><Data Set><Databases><Development><Disease><Disorder><Effectiveness><Encapsulated><Face><Future><GTEx><Generations><Genes><Genetic Alteration><Genetic Change><Genetic Diseases><Genetic defect><Genotype-Tissue Expression Project><Globin><Goals><Grippe><Half-Life><Hemagglutinin><Hemoglobin><Human><Immunity><In Vitro><Individual><Infectious Disease Pathway><Infectious Diseases><Infectious Disorder><Influenza><Influenza A><Influenza A virus><Influenza B><Influenza B Virus><Influenza Vaccines><Influenza Virus><Influenza Viruses Type A><Influenza Viruses Type B><Influenzavirus A><Injections><Intramuscular Injections><Investigators><Malignant Neoplasms><Malignant Tumor><Medicine><Messenger RNA><Methodology><Micro RNA><MicroRNAs><Modeling><Modern Man><Moderna COVID-19 vaccine><Moderna coronavirus disease 2019 vaccine><Muscle><Muscle Tissue><Mutation><Nipah Virus><Nipah henipavirus><Non-Polyadenylated RNA><ORFs><Open Reading Frames><Organ><Orthomyxovirus Type A><Orthomyxoviruses Type B><Pathogenicity><Performance><Pfizer covid19 vaccine><Pfizer-BioNTech COVID-19 vaccine><Pfizer-BioNTech coronavirus disease 2019 vaccine><Pfizer/BioNTech vaccine><Poly(A) Tail><Preventative measure><Preventative vaccine><Preventive measure><Preventive vaccine><Production><Prophylactic vaccine><Protein Coding Region><Proteins><Proteomics><Public Health><RNA><RNA Gene Products><RNA Stability><RNA vaccine><RNA-based vaccine><Recombinants><Research><Research Personnel><Researchers><Respiratory syncytial virus><Ribonucleic Acid><Role><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 vaccine><SARS-CoV2><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 vaccine><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Safety><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 vaccine><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 vaccine><Severe acute respiratory syndrome related corona virus 2><Software><Speed><Spikevax><Structure><Techniques><Technology><Testing><Therapeutic><Time><Tissues><Translations><Type A Influenza><UTRs><Untranslated Regions><Vaccinee><Vaccines><Viral Gene Products><Viral Gene Proteins><Viral Proteins><Virus><Visualization><Wuhan coronavirus><ZIKV><Zika Virus><cell type><clinical applicability><clinical application><coronavirus disease 2019 vaccine><coronavirus disease 2019 virus><coronavirus disease-19 vaccine><coronavirus disease-19 virus><data base><deep learning><deep learning based model><deep learning method><deep learning model><deep learning strategy><design><designing><developmental><egg><faces><facial><flu serotype><flu strain><flu subtype><flu vaccine><flu viral strain><flu virus strain><flu virus vaccine><genetic condition><genetic disorder><genome mutation><hCoV19><immunogen><imprint><improved><in silico><in vivo><influenza serotype><influenza strain><influenza subtype><influenza viral strain><influenza virus strain><influenza virus vaccine><influenzavirus><intramuscular drug administration><lipid based nanoparticle><lipid nanoparticle><mRNA><mRNA Leader Sequences><mRNA Stability><mRNA Translation><mRNA vaccine><mRNA-1273><mRNA-based vaccine><mRNA1273><malignancy><manufacture><miRNA><miRNAs><model design><muscular><nCoV vaccine><nCoV-19 vaccine><nCoV19 vaccine><nCoV2><neoplasm/cancer><novel><p-Globin><pandemic><pandemic disease><pre-clinical><preclinical><preservation><protein expression><prototype><respiratory pathogen><screening><screenings><seasonal flu><seasonal influenza><social role><success><tool><translation><vaccinated individual><vaccinated participant><vaccinated patient><vaccinated person><vaccinated subject><vaccine against 2019-nCov><vaccine against COVID-19><vaccine against SARS-CoV-2><vaccine against SARS-coronavirus-2><vaccine against Severe Acute Respiratory Syndrome CoV 2><vaccine against Severe acute respiratory syndrome coronavirus 2><vaccine against flu><vaccine against influenza><vaccine candidates against SARS-CoV-2><vaccine efficacy><vaccine for novel coronavirus><vaccines preventing COVID><vaccines to prevent COVID><virus protein><web site><website><zikav>